News

A year into the coronavirus pandemic, life in America remains almost unrecognizable. Noses and mouths remain hidden in public, gatherings remain verboten in many states, kitchen and dining room tables still function as work cubicles and classrooms, and take-out still subs for a night on the town. How long will the world stay this way?
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. And then there were three. The US Food and Drug Administration (FDA) today granted emergency use authorization (EUA) to the Ad26.COV2.S vaccine from Janssen/Johnson & Johnson (J&J) for people 18 and older after reviewing its safety and efficacy data. More vaccine
0 Comments
Serum neurofilament light (NfL), a marker of neuronal injury, was tied to multiple sclerosis (MS) disability, brain atrophy, and disease activity, a large real-world study showed. Among nearly 7,000 MS patients, those with elevated serum NfL had worse walking speed, manual dexterity, and processing speed; lower whole brain and thalamic volumes; and higher number of
0 Comments
Brian J. Gerber, Arizona State University and Melanie Gall, Arizona State University After one month in office, the Biden administration has fundamentally changed how the federal government responds to the COVID-19 pandemic. In direct contrast to his predecessor, President Joe Biden is treating this as a national-scale crisis requiring a comprehensive national strategy and federal
0 Comments
Feb. 26, 2021 — After several weeks of declining, COVID-19 numbers are back on the rise and new variants continue to emerge, according to White House officials — just as states begin to lift restrictions and open doors to restaurants and businesses. CDC Director Rochelle Walensky, MD, reported during a Friday COVID-19 briefing that coronavirus cases and
0 Comments
On Wednesday, the FDA announced that the Johnson and Johnson coronavirus vaccine was safe, more effective on serious cases of Covid-19 than on more moderate cases, and totally protective against hospitalizations and death.  Today, the independent group of infectious disease professionals that advises the FDA on whether a vaccine should receive a thumb’s up or
0 Comments
An FDA advisory panel lent their support today to a rapid clearance for Janssen/Johnson & Johnson’s COVID-19 vaccine. The Food and Drug Administration (FDA) is expected to quickly provide an emergency use authorization (EUA) for the vaccine following the recommendation by the panel. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 22-0 on
0 Comments
A majority of women with uncomplicated urinary tract infections (UTIs) received inappropriate antibiotics or continued treatment beyond the recommended duration, a review of almost 700,000 cases showed. Overall, 46.7% of patients received prescriptions for inappropriate antibiotics and 76.1% had inappropriately long duration of treatment. The frequency of inappropriate antibiotic agents was similar between urban and
0 Comments
by Sarah Kwon This story also ran on NBC News. For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19
0 Comments
In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said ‘Oh, my God!’ ” she recalled. “Super loud. My kids jumped up. My husband looked over. He said, ‘What’s wrong, what’s wrong, is everything OK?’ I was like, ‘No, no, it’s
0 Comments
Satjit Bhusri, MD, is worried about heart health, his own, and yours. A long-time New York City cardiologist, he is now treating the aftereffects of Covid-19. “What’s unusual about COVID…is that it is extremely inflammatory. That means the body attacks [the virus], and [the immune system] kind of goes overboard,” he said. What is unnerving
0 Comments
Multisystem inflammatory syndrome in children (MIS-C) has seen a surge in cases trailing the winter wave of COVID-19 in adults, but the treatment and recognition of it are better than in the earlier waves, clinicians and researchers say. Over the last 30 days, there have been around 11 cases of this SARS-CoV-2 infection-linked syndrome at
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two research teams have identified a new coronavirus variant in New York City and across the Northeast that could evade natural immune responses and some monoclonal antibody treatments, according to CNN. The variant, called B.1.526, has appeared in diverse neighborhoods in
0 Comments
In December, the Supreme Court reversed a lower court ruling that had allowed abortion medications to be sent by mail. Since then, women looking to terminate a pregnancy with the combination medications packet containing mifepristone and misoprostol now must go, in person, to a medical provider. But this in-person requirement is not necessary in many
0 Comments
Adding an immunomodulator to standard R-CHOP therapy failed to improve progression-free survival in high-risk diffuse large B-cell lymphoma (DLBCL), an international randomized trial showed. Although median progression-free survival (PFS) had yet to be reached, the trial did not meet the prespecified 37.5% reduction in hazard ratio (HR) with R-CHOP plus lenalidomide (Revlimid, R2-CHOP). Instead, adding
0 Comments
Results showing once-weekly subcutaneous semaglutide, as an adjunct to intensive behavioral therapy and an initial low calorie diet, induced weight loss that was 10.3% greater compared with placebo over 68 weeks in people with obesity or overweight, were published today in JAMA. The findings, from the phase 3, randomized, double-blind STEP 3 study for the
0 Comments
Data from an observational cohort study suggest that the presence of abandoned leads in patients with cardiac implantable electronic devices (CIEDs) should no longer be an absolute contraindication to MRI. In the study, which spanned 7 years and included 139 consecutive patients, adverse events were few, mild, and transient. The results were published online February
0 Comments
Not every cancer drug approved by the FDA receives approval and coverage in England and Canada, two studies in JAMA Internal Medicine showed. In England, a retrospective cohort study looked at 68 drugs given accelerated approval by the FDA from December 1992 to May 2017 that also received market approval in the European Union. The
0 Comments